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Regulation of intracellular calcium levels plays a cen-
tral role in cell survival, proliferation, and differentia-
tion. A cell-permeable, tumor-promoting thapsigargin
elevates the intracellular calcium levels by inhibiting
endoplasmic reticulum Ca21-ATPase. The Src-tyrosine
kinase family is involved in a broad range of cellular
responses ranging from cell growth and cytoskeletal re-
arrangement to differentiation. The immediate early
gene pip92 is induced in neuronal cell death as well as
cell growth and differentiation. To resolve the molecu-
lar mechanism of cell growth by intracellular calcium
mobilization, we have examined the effect of thapsigar-
gin and subsequent intracellular calcium influx on
pip92 expression in immortalized rat hippocampal
H19-7 cells. An increase of intracellular calcium ion lev-
els induced by thapsigargin stimulated the expression
of pip92 in H19-7 cells. Transient transfection of the cells
with kinase-inactive mitogen-activated protein kinase
kinase (MEK) and Src kinase or pretreatment with the
chemical MEK inhibitor PD98059 significantly inhibited
pip92 expression induced by thapsigargin. When consti-
tutively active v-Src or MEK was overexpressed, the
transcriptional activity of the pip92 gene was markedly
increased. Dominant inhibitory Raf-1 blocked the tran-
scriptional activity of pip92 induced by thapsigargin.
The transcription factor Elk1 is activated during thap-
sigargin-induced pip92 expression. Taken together,
these results suggest that an increase of intracellular
calcium ion levels by thapsigargin stimulates the pip92
expression via Raf-MEK-extracellular signal-regulated
protein kinase- as well as Src kinase-dependent signal-
ing pathways.
Research from many laboratories has shown that Ca21 in-
flux through ion channels can regulate gene expression by
multiple and diverse mechanisms. Activation of gene expres-
sion by Ca21 regulates fundamental biological responses, in-
cluding cell cycle, hormone secretion, and cell morphology (1). A
cell-permeable, tumor-promoting thapsigargin can cause a rise
in intracellular Ca21 levels (2).
Src family kinases are involved in a broad range of cellular
responses ranging from cell division and cytoskeletal rear-
rangement in fibroblasts to the differentiation of neuronal
PC12 cells (3–5). v-Src is a constitutively active protein-ty-
rosine kinase that results in cellular transformation, and v-Src
mutants deficient in kinase activity do not transform cells,
suggesting that phosphorylation of specific cellular targets is
important for the transformed phenotype induced by v-Src (6).
Many putative substrate proteins have been identified. Ras
and Raf have been reported to be required for the transformed
phenotype induced by v-Src (7, 8). Although Ras is not a sub-
strate of v-Src, and Raf is phosphorylated on tyrosine, Raf
functions downstream of Ras (9).
The immediate early gene pip92 was cloned from activated T
lymphocytes treated with cycloheximide (10) and serum-stim-
ulated BALB/c 3T3 fibroblasts (11). pip92 is rapidly and tran-
siently induced by stimulation with serum and growth factors
in fibroblasts. In addition to cell growth, pip92 is also induced
during neuronal differentiation by differentiating factors (12).
Although pip92 encodes a short-lived, proline-rich protein with
no significant sequence similarity to any known protein, little
is known about the function of its encoded protein.
Previously it was shown that thapsigargin-induced release of
intracellular Ca21 activated mitogen-activated protein kinase
(MAPK)1 and extracellular signal-regulated protein kinase
(ERK) (13). This activation is independent of protein kinase C
or Ca21 influx but requires the presence of Raf-1 (14). Src-
tyrosine kinase mediates the stimulation of Raf-1 and ERK by
thapsigargin (15). Recently, we have observed that pip92 is
expressed in the mouse brain after a single intraperitoneal
injection of excitatory amino acid NMDA (16). Many actions of
NMDA are coupled to the influx of extracellular Ca21 mediated
directly or indirectly by its receptor present in neurons, and
transient changes in intracellular Ca21 levels are known to
trigger a number of cellular responses, including change of
gene expression (17). Ca21 is known to activate ERK signaling
in neuronal PC12 and H19-7 cells (15, 18). On the basis of those
findings, it was suggested that the calcium ion and Src kinase
could regulate the pip92 expression. To resolve the mechanism
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of thapsigargin-induced cell growth, we analyzed whether
pip92 expression is induced by thapsigargin subsequently fol-
lowed by intracellular free Ca21 mobilization and whether the
activation of ERK and Src kinase is involved. The results
indicated that an increase of intracellular calcium ion levels by
thapsigargin stimulates pip92 expression via ERK- as well as
Src kinase-dependent signaling pathways, suggesting that
pip92 is likely to play a role in thapsigargin-induced neuronal
cell growth.
EXPERIMENTAL PROCEDURES
Materials—Fetal bovine serum, Dulbecco’s modified Eagle’s medium
(DMEM), and G418 were purchased from Life Technologies, Inc. Thap-
sigargin, ionomycin, and PD98059 were purchased from Calbiochem.
All other used chemicals were commercial products of analytical grade
from Sigma. The pip92 promoter-chloramphenicol acetyltransferase
(CAT) reporter fusion construct (21281pip92/CAT) was provided by
L. F. Lau. Plasmids encoding v-Src and kinase-inactive mutant Src
were kindly provided by D. Foster, and plasmids for kinase-inactive
MAPK kinase (MEK-2A) and constitutively active MEK (MEK-2E)
were obtained from G. Johnson. The plasmid encoding a dominant
inhibitory Raf-1 kinase (Raf-KR) was given by C. Marshall. Plasmid
GST-ElkC, expressing glutathione S-transferase fused to the C-termi-
nal peptide (amino acids 307–428) of wild type Elk1 was provided by R.
Treismann.
Cell Culture—The rat neuronal hippocampal cell line H19-7 was
generated by transduction with the retroviral vectors containing the
temperature-sensitive simian virus 40 large T antigen that is function-
ally active at 33 °C and inactive at 39 °C (19). The cells were cultured at
33 °C in DMEM containing 10% fetal bovine serum and 200 mg/ml G418
to maintain selection pressure on the transduced immortalization vec-
tor. When specified, cells were pretreated with 30 mM synthetic MEK
inhibitor PD98059 for 30 min before drug stimulation.
Determination of DNA Synthesis—DNA synthesis was measured by
use of [3H]thymidine incorporation. The H19-7 cells were suspended by
trypsinization, counted, and replated into 24-well plates at a density of
30,000 cells/well in media containing 10% fetal bovine serum. The cells
were starved in 0.5% fetal bovine serum for 48 h to decrease the cell
proliferation and to induce quiescence. Then the media were changed to
DMEM plus 10% fetal bovine serum with or without thapsigargin. The
cells were incubated with thymidine (1 mCi/well) during the last 4 h. At
the end of the incubation, the medium was aspirated, and the cells were
washed three times with cold DMEM and then solubilized with Protosol
(NEN Life Science Products). Radioactivity was measured with a Beck-
man scintillation counter.
Measurement of Intracellular Calcium Levels—For Ca21 measure-
ment, Fura-2 loading and fluorescence analyses were carried out as
described previously (20). The cells were maintained in DMEM contain-
ing 10% fetal bovine serum and plated on a sterile 22 3 22-mm coverslip
at a density of 2.5 3 105 cells/cm2. At the confluence of 70–80%, the
cells were washed twice with a HEPES-buffered solution (solution A)
and loaded with Fura-2 by a 30-min incubation at room temperature in
solution A containing 5 mM Fura-2/AM (Molecular Probes, Eugene, OR).
Solution A contained 140 mM NaCl, 5 mM KCl, 1 mM MgCl2, 1 mM
CaCl2, 10 mM glucose, and 10 mM HEPES, pH 7.4. After the loading, the
coverslips were washed once with solution A and assembled to form the
bottom of perfusion chamber. The chamber was continuously perfused
with either a Ca21-containing solution (solution A) or a Ca21-free solu-
tion (solution B). Ca21-free solution B was prepared by replacing CaCl2
with 3 mM EGTA. The osmolarity of all solutions was adjusted to 310
mOsm with the major salts before use. Fluorescence was measured and
calibrated using a PTI system (PTI Delta Ram, New Brunswick, NJ) as
described previously (20). Fura-2 fluorescence was excited at 355 and
380 nm and calibrated by exposing the cells to solutions containing high
and low concentrations of Ca21 and 10 mM ionomycin.
DNA Transfection and CAT Assay—Transient transfection was per-
formed by using LipofectAMINE Plus reagents (Life Technologies) as
described by the manufacturer’s protocol. Plasmid pCMV-GAL, which
contains the Escherichia coli b-galactosidase gene driven by the cyto-
megalovirus, promoter was used as an internal control to determine
transfection efficiency. The CAT assay was done with an enzyme-linked
immunosorbent assay CAT assay kit (5 Prime3 3 Prime, Inc., Boulder,
CO).
RNA Preparations and Northern Blot Analysis—Total cellular RNAs
from H19-7 cells were isolated by the single-step extraction procedure
using guanidium isothiocyanate as described elsewhere (21). Northern
blot analysis to measure pip92 mRNA levels was done as described
previously (12).
Src Kinase Assay—Src-tyrosine kinase activity was measured by
phosphorylation of rabbit muscle enolase as described previously (15).
The samples were resolved on a 12.5% SDS-polyacrylamide gel, and the
phosphorylation level of enolase was measured by scintillation counting
of excised protein bands.
Immunoprecipitation and Assay of Hemagglutinin (HA)-tagged ERK2—
ERK2 kinase activity was measured by immunoprecipitation of the epitope-
tagged Erk2, followed by an in vitro phosphorylation assay as described
previously (12). Transfected cells were stimulated and lysed with solution C,
consisting of 20 mM Tris, pH 7.9, 137 mM NaCl, 5 mM Na2EDTA, 10%
glycerol, 1% Triton X-100, 0.2 mM p-methylsulfonylfluoride, 1 mg/ml aproti-
nin, 20 mM leupeptin, 1 mM sodium o-vanadate, pH 10.0, 1 mM EGTA, 10 mM
NaF, 1 mM tetrasodium pyrophosphate, 1 mM b-glycerophosphate, pH 7.4,
and 0.1 g/ml p-nitrophenylphosphate. The cell lysates were then incubated
with protein A-Sepharose coupled with the anti-HA antibody (Santa Cruz
Biotechnologies) for 24 h at 4 °C. The immune complexes were washed with
lysis buffer and with kinase reaction buffer containing 20 mM HEPES, pH
7.4, 10 mM MgCl2, 1 mM dithiothreitol, 200 mM o-vanadate, and 10 mM
p-nitrophenylphosphate. The assay of immunoprecipitated HA-tagged
ERK2 was done using myelin basic protein as a substrate as described
previously (12).
Electrophoretic Mobility Shift Analysis—Nuclear extracts were pre-
pared from H19-7 cells as described elsewhere (22). An electrophoretic
mobility shift analysis assay was performed as described previously
(23).
In Vitro Assay of Elk1 Phosphorylation—In vitro Elk1 phosphoryla-
tion by using gluthathione-Sepharose 4B beads (Amersham Pharmacia
Biotech) was examined as described previously (23).
RESULTS
Thapsigargin Stimulates DNA Synthesis in Rat Hippocam-
pal Neuronal Cells—Immortalized H19-7 cells were generated
from rat hippocampal neurons. Initially, we investigated how
the stimulation of the H19-7 cells with thapsigargin affects cell
growth. Thapsigargin in the range of 0.1–10 mg/ml induced a
concentration-dependent increase in DNA synthesis measured
by [3H]thymidine incorporation (Fig. 1). Stimulation of the cells
with 10 mg/ml thapsigargin for 24 h increased the DNA incor-
poration ;1.6-fold compared with that of control cells in the
absence of thapsigargin. These data indicated that thapsigar-
gin stimulates the proliferation of neuronal H19-7 cells.
Thapsigargin and Ionomycin Cause Mobilization of Intracel-
lular Calcium Levels in H19-7 Cells—To examine whether
thapsigargin causes a change in intracellular calcium levels,
cells were preloaded with Fura-2 and then monitored for
changes in intracellular calcium after exposure to thapsigargin
in medium containing 1 mM calcium. The time courses of cal-
FIG. 1. Thapsigargin stimulates DNA synthesis in H19-7 cells.
Cells were incubated in DMEM including 10% fetal bovine serum with
the indicated concentration of thapsigargin for 24 h. Cell cultures were
labeled with [3H]thymidine during the last 4 h of incubation and ana-
lyzed for DNA synthesis, as described under “Experimental Proce-
dures.” Data are shown as percentage of control (vehicle in media), and
all histograms represent the mean of three replicates.
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cium mobilization by thapsigargin are shown in Fig. 2. By ;5
min after addition of 10 mg/ml thapsigargin, cytosolic free cal-
cium levels had increased from ;70 to 250 nM, followed by a
long plateau. Although there was some variation in the shape
of the calcium profile, depending on the particular cell being
monitored, in general thapsigargin caused a gradual increase
followed by a long plateau phase. Ionomycin also increases the
calcium levels by channeling through membranes from a non-
specific source (24). In the same way, addition of 1 mM ionomy-
cin increased the intracellular calcium levels up to ;1500 nM,
reaching a peak by 1–2 min. Addition of EGTA to the cells
during the plateau phase dropped the calcium down to basal
levels.
Induction of pip92 by Intracellular Calcium Mobilization in
H19-7 Cells—Next we examined whether intracellular calcium
mobilization induced by thapsigargin causes the stimulation of
pip92 expression in H19-7 cells. We first measured the time
course of pip92 mRNA expression by thapsigargin. Northern
blot analysis showed that pip92 is expressed rapidly and tran-
siently within 30–60 min after 10 mg/ml thapsigargin stimu-
lation (Fig. 3A) but not with vehicle. Transcriptional activation
of the pip92 gene was examined by using a CAT reporter
plasmid linked to a 21281-base pair pip92 promoter fragment
(21281pip92/CAT) transiently expressed in H19-7 cells. The
21281-base pair pip92 promoter fragment was shown to medi-
ate serum induction in a manner that closely mimics the en-
dogenous gene (25). Treatment of the cells with 10 mg/ml thap-
sigargin caused rapid stimulation of pip92 transcriptional
activity, which reached a plateau by 1 h as monitored by CAT
assay (Fig. 3B). Mock-transfected control cells did not activate
the pip92 promoter (data not shown). A similar level of pip92
mRNA and its transcription were induced with 1 mM calcium
ionophore ionomycin, and an additive increase of pip92 tran-
scription was not observed by the cotreatment with thapsigar-
gin and ionomycin (data not shown).
Kinase-inactive Src or MEK Inhibitor Blocks Thapsigargin-
induced Activation of pip92 Induction—Many studies demon-
strated a role for pp60SRC-tyrosine kinase (Src) in Ca21-in-
duced cell cycle progression and mitogenesis (26–28). To test
that Src kinase functions as a mediator for thapsigargin and
calcium signaling in H19-7 cells, we assayed the Src kinase
activity in response to thapsigargin. Fig. 4A shows that thap-
sigargin activates Src-tyrosine kinase 2.5-fold. Transfection of
kinase-deficient Src mutant resulted in the inhibition of thap-
sigargin-induced Src kinase activity to the basal level in H19-7
cells, suggesting that thapsigargin may use Src kinase for
downstream signaling events. To test whether MAP kinase is
also a downstream target of thapsigargin-induced calcium mo-
bilization, the cells were transiently transfected with a kinase-
inactive MEK mutant (MEK-2A), which encodes a protein with
2 alanine residues substituted at the sites of the activating
serine residues, together with an HA epitope-tagged ERK2.
The addition of thapsigargin resulted in the significant in-
crease of ERK activity, measured by using an epitope-tagged
ERK2-immune complex kinase assay (Fig. 4B), and kinase-
deficient MEK-2A completely blocked the thapsigargin-in-
duced HA-ERK2 activity. To further verify the role of MEK-
ERK activation by thapsigargin, we measured the ERK2
activity by thapsigargin after pretreating the cells with 30 mM
MEK inhibitor PD98059 for 30 min. Previously we have shown
that activation of ERK by fibroblast growth factor (FGF) is
completely blocked by 30 mM PD98059 in H19-7 cells (29).
Addition of MEK inhibitor also significantly blocked the thap-
sigargin-induced HA-ERK2 activity. In all samples, ERK2 en-
zymes were present at the same levels. These results suggest
that calcium mobilization by thapsigargin activates both ERK
and Src kinase in H19-7 cells.
To test whether pip92 is activated via the activation of Src
FIG. 2. Thapsigargin and ionomycin triggered calcium mobili-
zation in H19-7 cells. The cells were preloaded with Fura-2 and
perfused with calcium-containing HEPES-buffered solution A to estab-
lish basal Ca21 levels at 33 °C. Subsequently, the cells were treated
with 10 mg/ml thapsigargin (Tg; A) or 1 mM ionomycin (Iono; B), followed
by the addition of Ca21-free EGTA, as indicated. Each trace is from an
individual cell in a field of cells and represents a typical response of
three independent experiments.
FIG. 3. Induction of immediate early gene pip92 by thapsigar-
gin in neuronal H19-7 cells. A, H19-7 cells were treated with 10
mg/ml thapsigargin (Thap) or vehicle (Veh) at 33 °C for the indicated
times. A 10-mg aliquot of total RNA was extracted from cells, applied to
each lane, and hybridized to a 125-base pair 32P-labeled pip92 cDNA
fragment. As a control for RNA loading, total RNA was hybridized to
32P-labeled glyceraldehyde-3-phosphate dehydrogenase (GAPDH)
cDNA probe. B, 2 mg of CAT reporter plasmid linked to the 21,281-base
pair pip92 promoter fragment (21281pip92/CAT) was transiently
transfected into H19-7 cells. After treatment of the cells with 10 mg/ml
thapsigargin, the activity of the expressed CAT enzyme in 40–60 mg of
cell lysates was measured at the indicated times. Data are plotted as
the mean plus the range of samples from three independent experi-
ments performed in triplicate.
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kinase and ERK in response to thapsigargin, the H19-7 cells
were transiently transfected with the combination of
21281pip92/CAT and a kinase-inactive Src or MEK-2A, and
transcriptional activity of pip92 by thapsigargin was meas-
ured. As shown in Fig. 4C, thapsigargin-induced activation of
the pip92 promoter was significantly blocked by the Src kinase
mutant. In the presence of kinase-inactive MEK-2A, transcrip-
tional activation of pip92 by thapsigargin was also significantly
decreased (Fig. 4C). In an effect similar to that of MEK-2A,
pretreatment of the cells with the MEK inhibitor remarkably
suppressed pip92 expression by thapsigargin. The induction of
pip92 mRNA levels by thapsigargin was also greatly reduced
by mutant Src, MEK-2A, or PD98059, measured by Northern
blot analysis (Fig. 4D), suggesting that the regulation of the
episomally expressed pip92 reporter does reflect mRNA expres-
sion from the endogenous gene. Overall these results indicated
that the activation of Src kinase and ERK is necessary for
thapsigargin-induced activation of pip92.
Constitutively Active Src Kinase and MEK Increase Basal
pip92 Expression in Neuronal H19-7 Cells—v-Src is a consti-
tutively active tyrosine kinase. To test whether Src kinase is
sufficient for mediating thapsigargin-induced activation of
MAP kinase and pip92 expression, v-Src was transfected into
H19-7 cells together with 21281pip92/CAT or HA-ERK2 plas-
mid. Expression of constitutive v-Src kinase in H19-7 cells
resulted in a significant increase in pip92 transcriptional ac-
tivity (Fig. 5) and activation of ERK in a constitutive manner,
which is comparable with that by thapsigargin (Fig. 6B). In a
similar way, transient transfection of the constitutively active
MEK mutant (MEK-2E), which encodes a protein with 2 glu-
tamic acid residues substituted at the sites of the activating
serine residues, markedly induced pip92 transcription without
thapsigargin treatment (Fig. 5). It was previously shown that
expression of MEK-2E is effective at generating constitutively
active MAPK, and the activity is comparable with that induced
by growth factor stimulation of the cells (30). Pretreatment of
the cells with 30 mM MEK inhibitor also blocks the pip92
expression induced by v-Src or MEK-2E treatment (Fig. 5).
Previously, it was also shown that dominant negative Src
blocks thapsigargin-induced activation of ERK (15). Taken to-
gether, these results confirmed that ERK activation is neces-
sary for the Src kinase-induced pip92 activation.
Dominant Inhibitory Raf-1 Mutant Blocks Thapsigargin-in-
duced pip92 Expression—To further characterize the effect of
FIG. 4. Dominant-negative Src kinase mutant, kinase-inactive MEK, or chemical MEK inhibitor blocks thapsigargin-induced
pip92 expression. A, where specified, H19-7 cells were transfected with 10 mg of kinase-deficient Src mutant plasmid (mSrc) or parental vector
(control). The cells were stimulated with 10 mg/ml thapsigargin (Thap) or vehicle for 1 h, and then Src kinase activity was measured as the
phosphorylation of rabbit muscle enolase. B, the cells were transfected with 2.5 mg of an HA-tagged ERK2 plasmid (HA-ERK) or together with 10
mg of a kinase-inactive MEK mutant (MEK-2A), as indicated. After transfection, the cells were stimulated with 10 mg/ml thapsigargin (Thap) for
1 h. Where indicated, cells were pretreated with 30 mM MEK inhibitor (MI) PD98059 for 30 min before cell harvest. The HA-tagged ERK2 was
assayed for kinase activity by using myelin basic protein (MBP) as a substrate. As a control for equal protein loading, HA-tagged ERK2 levels were
measured by Western analysis using anti-HA antibodies. C, where indicated, 2 mg of 21281pip92/CAT plasmid DNA was transiently cotransfected
into H19-7 cells with 10 mg of a kinase-inactive Src (mSrc) or MEK mutant (MEK-2A). After H19-7 cells were either untreated or pretreated with
30 mM MEK inhibitor (MI) PD98059 for 30 min, the cells were stimulated with vehicle (Control) or 10 mg/ml thapsigargin (T) for 1 h. The
transcriptional activity of pip92 was measured by CAT assay. Data are plotted as the mean plus the range of samples from two independent
experiments performed in duplicate. D, where indicated, the cells were transiently transfected with 10 mg of a kinase-inactive Src (mS) or MEK-2A
mutant (mM). Where specified, H19-7 cells were pretreated with 30 mM MEK inhibitor (MI) PD98059 for 30 min. The cells were then stimulated
with 10 mg/ml thapsigargin (Thaps) or vehicle (Con) for 1 h, and Northern blot analysis of pip92 mRNA was done. GAPDH, glyceraldehyde-3-
phosphate dehydrogenase.
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Raf-1 activity on the thapsigargin-induced signaling pathway
leading to the induction of pip92, we transiently transfected
the cells with the kinase-inactive Raf-1 mutant (Raf-KR) and
measured the induction of pip92 transcriptional activity by
thapsigargin. As shown in Fig. 6A, the dominant negative
Raf-1 mutant suppressed pip92 induction by thapsigargin sig-
nificantly. In a similar way, when the cells were cotransfected
with constitutively active v-Src and kinase-deficient Raf-KR,
the pip92 activation was blocked remarkably. To further deter-
mine the requirement of Raf-1 for thapsigargin-induced MAP
kinase signaling, we transiently transfected the H19-7 cells
with Raf-KR with an HA-tagged ERK2 plasmid. As analyzed by
an epitope-tagged ERK2 immune complex assay (Fig. 6B), the
dominant negative Raf-KR mutant blocks the epitope-tagged
ERK2 activity induced by thapsigargin and v-Src kinase. The
data indicate that Raf-1 kinase is required for thapsigargin-
induced MAP kinase activation and pip92 expression.
Activation of Transcription Factor Elk1 during Thapsigar-
gin-induced pip92 Expression—Previous studies have shown
that serum response element (SRE) present in the pip92 pro-
moter can interact with recombinant serum response factor
(SRF) and Elk1 proteins forming a tertiary complex (16, 25).
Elk1 can be phosphorylated by ERK, and it is critical for
transcriptional activation of pip92 and c-fos. Next we examined
whether Elk1 can be phosphorylated by thapsigargin. After
cells were stimulated with 10 mg/ml thapsigargin, nuclear ex-
tracts and cell lysates were prepared. Electrophoretic mobility
shift analysis using pip92 SRE oligonucleotide and anti-phos-
pho-Elk1 antibodies showed that endogenous Elk1 does not
bind to the pip92 SRE element without stimulation and is
activated by thapsigargin (Fig. 7A). The cell lysates were incu-
bated in the presence of radiolabeled ATP with the wild-type
GST-Elk1 C terminus (GST-ElkC) prebound to Sepharose 4B
beads. As shown in Fig. 7B, wild-type GST-ElkC was phospho-
rylated by extracts from the cells stimulated with thapsigargin.
To demonstrate that the phosphorylation of GST-ElkC by nu-
clear extracts from thapsigargin-treated cells is specifically
mediated by ERK and Src kinase, the effect of the inhibition of
ERK or Src kinase activity was examined. Pretreatment of the
cells with PD98059 before stimulation or removal of ERK by
the incubation of cell lysates with agarose-ERK-immunoglobu-
lin after stimulation resulted in a complete block of GST-ElkC
phosphorylation by cell lysates. Similarly, transfection of ki-
nase-inactive MEK and the Src mutant remarkably inhibited
GST-ElkC phosphorylation by thapsigargin-induced cell ly-
sates. These results implied that Src kinase and ERK mediate
thapsigargin-induced activation of pip92 via the phosphoryla-
tion of Elk1.
DISCUSSION
Thapsigargin, a non-phorbol ester-type tumor promoter, dis-
charges intracellular Ca21 stores by specific inhibition of the
endoplasmic reticulum Ca21-ATPase. Although the mecha-
nism of tumor promotion by thapsigargin is not well under-
stood, treatment of mouse NIH 3T3 fibroblasts with thapsigar-
gin induced rapid expression of the c-fos and c-jun
protooncogenes (31). Furthermore, thapsigargin could syner-
gize with another tumor promoter, phorbol 12-myristate 13-
acetate, to induce c-fos but not c-jun. The stress-inducible glu-
cose-regulated proteins, a class of calcium binding molecular
chaperones localized in the endoplasmic reticulum, have been
implicated in the development of thapsigargin-induced tumor-
igenicity (32). In addition, the present study suggests that
Elk1-dependent activation of pip92 might contribute the tu-
morigenesis of thapsigargin in neuronal cells.
It has been well documented that thapsigargin and ionomy-
cin mobilize Ca21 through distinct mechanisms, thapsigargin
by inhibiting microsomal Ca21-ATPases and ionomycin by
channeling calcium through the membrane from nonspecific
sources (33). On the basis of the finding that both thapsigargin
and ionomycin are able to induce pip92 expression, and there
was no synergistic effect by the coaddition of the two agents
(Fig. 2), Ca21 appears to be a common mediator for the pip92
induction. Although the two drugs produced a 6–7-fold differ-
ential increase of intracellular calcium levels, similar levels of
pip92 induction were observed, suggesting that a slight in-
crease of intracellular calcium mobilization by thapsigargin is
likely to be sufficient to induce pip92.
Previously we demonstrated that pip92 is expressed rapidly
and transiently during NMDA-induced cell death in H19-7 cells
(16). In the present study we have shown that pip92 is also
expressed during thapsigargin-induced cell proliferation. Both
processes are commonly mediated by the increase of intracel-
lular Ca21 influx. Many of the same immediate early genes
such as c-fos and pip92 are induced in a variety of biological
contexts as diverse as mitogenic responses and the cellular
response to cytotoxic stimuli. It will be interesting to investi-
gate the molecular mechanism of variable biological responses
FIG. 5. Effect of constitutively ac-
tive MEK and Src kinase on pip92 ex-
pression in H19-7 cells. Where indi-
cated, 2 mg of 21281pip92/CAT plasmid
DNA was transiently transfected into
H19-7 cells with 5 mg of a parental vector
(Control), constitutively active Src (v-Src)
or MEK mutant (MEK-2E). When speci-
fied, cells were treated with 30 mM
PD98059 for 30 min (MI), and the tran-
scriptional activity of pip92 was meas-
ured by CAT assay. Data are plotted as
the mean plus the range of samples from
two independent experiments performed
in duplicate.
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resulting from the use of genes of which products are used in
many contexts. The mechanism may be triggered as a conse-
quence of differential quantitation of different ligands or dif-
ferent kinetics of the induction of immediate early genes and
their products. Because Ca21 signals are short-lived when com-
pared with alterations in differentiated gene expression, it is
generally considered that genes coding for short-lived tran-
scription factors (e.g. c-fos and c-jun) are the immediate targets
of Ca21 signaling (34, 35). On the basis of the previous finding
that Pip92 is selectively expressed in the nucleus as a fusion
with green fluorescent protein (23), Pip92 seems to be a second
messenger, for example, as a transcription factor, rather than
a direct effector of a variety of cell responses, such as cell
growth, differentiation, and transformation. We are currently
investigating the functional roles of the Pip92 protein in the
nucleus.
Previously we have shown that both FGF and Raf activate
MAPK-independent kinases that can stimulate Elk1 phospho-
rylation and pip92 transcription (12). An increase of intracel-
lular calcium levels by thapsigargin or ionomycin caused a
rapid and transient increase of pip92 gene expression, and the
signals for intracellular calcium mobilization are transmitted
through the activation of Src kinase- and Raf-MEK-ERK-de-
pendent signaling pathways in H19-7 cells. Elk1 becomes a
transcriptional activator to induce pip92 in response to thap-
sigargin. However, because of a previous finding that kinase-
inactive Src kinase did not completely block the activation of
ERK by FGF and neuronal differentiation by Raf-1 activation
(29), Src-tyrosine kinases appear to be differentially activated
via distinct signaling pathways by FGF and thapsigargin in
H19-7 cells.
Many studies demonstrated a role for Src kinase in intracel-
lular calcium signaling. For example, functional calcium-sens-
ing receptors in rat fibroblasts are required for activation of Src
kinase and mitogen-activated protein kinase in response to
extracellular calcium (36). The Src kinase pathway is involved
in Ca21-dependent pancreatic exocytosis (37), and angiotension
II-induced phosphorylation of p130Cas by Src family tyrosine
kinases is dependent on intracellular calcium and protein ki-
nase C (38). Considerable evidence also supports the role of Src
family kinases in the stimulation of ERK. Many G protein-
coupled receptors initiate Ras-dependent activation of the ERK
cascade by inducing the tyrosine phosphorylation of proteins
that serve as scaffolds for the plasma membrane recruitment of
Ras guanine exchange factors. Activation of Src kinase by the
a-thrombine (39), lysophosphatidic acid (40), angiotension II
(41), N-formyl peptide chemoattractant (42), a2A-adrenergic
(39, 40), and M1 muscarinic receptors (41) has been reported.
A number of studies have suggested that Src cooperates with
FIG. 6. Transcriptional activation of pip92 by thapsigargin
and v-Src is inhibited by dominant-inhibitory Raf-1. A, two mi-
crograms of 21281pip92/CAT reporter plasmids or with 10 mg of a
kinase-inactive Raf mutant (T1Raf-KR) were transiently transfected
into H19-7 cells, as indicated, and the cells were stimulated with vehicle
(Control) or 10 mg/ml thapsigargin (Thap) for 1 h. Where specified, 2 mg
of 21281pip92/CAT plasmid was transiently transfected into the cells
with 10 mg of oncogenic v-Src or a combination with 5 mg of Raf-KR
(S1Raf-KR). The transcriptional activity of pip92 was measured at
33 °C as described under “Experimental Procedures.” Data are plotted
as the percentage of pip92 transcriptional activity by thapsigargin and
represent the mean plus the range of samples from two independent
experiments. B, the cells were transiently transfected with 1 mg of
HA-ERK2 plasmid with or without 5 mg of kinase-inactive Raf (Raf-KR)
and/or constitutively active src (v-Src) plasmid. After transfection, the
cells were stimulated with 10 mg/ml thapsigargin (Thap) for 1 h, and the
kinase activity of HA-ERK2 was measured as described in Fig. 3B. As
a control for equal protein loading, HA-tagged ERK2 levels were meas-
ured by Western analysis using anti-HA antibodies. MBP, myelin basic
protein.
FIG. 7. Activation of endogenous Elk1 by thapsigargin and
inhibition of in vitro Elk1 phosphorylation by kinase-inactive
Src kinase and ERK. A, nuclear extracts from control H19-7 cells or
cells stimulated with 10 mg/ml thapsigargin (Thaps) were incubated
with end-labeled SRE oligonucleotide, and the resulting protein-DNA
complexes were resolved by nondenaturing polyacrylamide gel electro-
phoresis. For Elk1 supershift analysis, after binding, 0.5 mg of phospho-
Elk1 antibodies were added, and the reaction mixture was incubated at
4 °C for 2 h before gel electrophoresis. In lanes 2–4, 100-fold excesses of
various oligonucleotides (SRE, kB, and AP-1) were included as compet-
itors, as indicated above each lane. In lane 5, antibodies against phos-
pho-Elk1 (pElk1) were included. One SRE-protein complex and a su-
pershifted SRE-phospho-Elk1 binding complex are denoted are denoted
by open and filled arrows, respectively. Lane 6, control cells without
stimulation. Nonspecific complex (NS) and free probe (probe) are indi-
cated on the left. B and C, where specified, 5 mg DNA of a kinase-
inactive Src mutant (mS) or MEK-2A (M2A) was transiently trans-
fected into H19-7 cells. Where indicated, the cells were pretreated with
30 mM PD98059 for 30 min (PD), followed by the stimulation with 10
mg/ml thapsigargin (Thaps). With the cell extracts, prepared from ve-
hicle-treated (Veh), thapsigargin-stimulated cells or incubated with
agarose-ERK-antibody (A-ERK) after stimulation, containing 50–60 mg
of proteins and 75 ml of Sepharose 4B beads, in vitro Elk1 phosphoryl-
ation was performed as described under “Experimental Procedures.”
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Ras to activate MAP kinase in some signaling events. For
example, activation of Src family kinases and Ras is required
for activation of ERKs by angiotension II in smooth muscle
cells (43). Oxidative stress, such as H2O2, activates ERKs
through Src kinase in cultured cardiac myocytes of neonatal
rats (44). However, conflicting results also have been reported
to indicate that both can activate independent pathways in
certain instances. In fibroblast NIH3T3 cells, Myc, but not Fos
or Jun, was able to rescue the inhibition of platelet-derived
growth factor-stimulated DNA synthesis by dominant negative
Src, whereas Fos and Jun, but not Myc, rescued the cell growth
block given by dominant negative Ras (45). Src appears to
activate a Ras- and Raf-independent pathway during the dif-
ferentiation of H19-7 cells by FGF (29). Studies using dominant
inhibitory Raf-1 mutants also indicate that Src can be an up-
stream activator for Raf-1, and Raf-1 may be required for the
Src-dependent activation of MAP kinase (15).
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